These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2544821)

  • 1. Effects of physiological infusion of atrial natriuretic factor on healthy subjects and patients with the nephrotic syndrome.
    Woolf AS; Lyon TL; Hoffbrand BI; Cohen SL; Moult PJ
    Nephron; 1989; 52(3):244-50. PubMed ID: 2544821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
    Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
    Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal and endocrine effects of physiological variations of atrial natriuretic factor in normal humans.
    Bruun NE; Skøtt P; Giese J
    Am J Physiol; 1991 Jan; 260(1 Pt 2):R217-24. PubMed ID: 1847023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
    Plum J; Mirzaian Y; Grabensee B
    Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal sites of action of physiological increases in plasma atrial natriuretic factor concentration in essential hypertension.
    Bruun NE; Skøtt P; Giese J
    J Hypertens; 1992 Jan; 10(1):37-47. PubMed ID: 1312549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of atrial natriuretic factor [alpha-human ANF-(99-126)] in the hormonal and renal adaptation to sodium deficiency.
    Beland B; Tuchelt H; Bähr V; Oelkers W
    J Clin Endocrinol Metab; 1994 Jul; 79(1):183-8. PubMed ID: 8027224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan improves the natriuretic response to ANF in rats with high-output heart failure.
    Abassi ZA; Kelly G; Golomb E; Klein H; Keiser HR
    J Pharmacol Exp Ther; 1994 Jan; 268(1):224-30. PubMed ID: 8301562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of frusemide on atrial natriuretic peptide, guanosine cyclic monophosphate, angiotensin II, aldosterone, vasopressin, prostaglandin E2 and blood volume in the nephrotic syndrome.
    Jespersen B; Sørensen SS; Pedersen EB
    Nephrol Dial Transplant; 1991; 6(6):402-9. PubMed ID: 1652115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril enhances renal responsiveness to ANF in dogs with compensated high-output heart failure.
    Villarreal D; Freeman RH; Johnson RA
    Am J Physiol; 1992 Mar; 262(3 Pt 2):R509-16. PubMed ID: 1313653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of renal responsiveness to atrial natriuretic peptide in experimental nephrotic syndrome by albumin infusion.
    Abassi Z; Weissman I; Karram T; Goltsman I; Hoffman A; Better OS; Winaver J
    Am J Nephrol; 2013; 38(4):292-9. PubMed ID: 24080549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome.
    Valentin JP; Qiu C; Muldowney WP; Ying WZ; Gardner DG; Humphreys MH
    J Clin Invest; 1992 Oct; 90(4):1302-12. PubMed ID: 1328296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma atrial natriuretic peptide and natriuretic response to water immersion in patients with nephrotic syndrome.
    Hwang SJ; Tsai JH; Lai YH; Chen JH
    Nephron; 1991; 58(3):330-8. PubMed ID: 1832746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ANF-mediated renal cGMP generation in congestive heart failure.
    Margulies KB; Heublein DM; Perrella MA; Burnett JC
    Am J Physiol; 1991 Apr; 260(4 Pt 2):F562-8. PubMed ID: 1849364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blunted natriuresis to atrial natriuretic peptide in chronic sodium-retaining disorders.
    Koepke JP; DiBona GF
    Am J Physiol; 1987 May; 252(5 Pt 2):F865-71. PubMed ID: 2953252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of atrial natriuretic factor, cyclic GMP and the renin-aldosterone system in acute volume regulation of healthy human subjects.
    Gerbes AL; Arendt RM; Gerzer R; Schnizer W; Jüngst D; Paumgartner G; Wernze H
    Eur J Clin Invest; 1988 Aug; 18(4):425-9. PubMed ID: 2844547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coadministration of albumin and furosemide in patients with the nephrotic syndrome.
    Fliser D; Zurbrüggen I; Mutschler E; Bischoff I; Nussberger J; Franek E; Ritz E
    Kidney Int; 1999 Feb; 55(2):629-34. PubMed ID: 9987087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.